Search research articles
Contact Us
Filters
Showing results (171-180 of 214) with videos related to
Page
of 22
Sort By:
Cancer
|
August 27, 2004
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies
Maher Albitar, Kim-Anh Do, Marcella M Johnson, et al.
British Journal of Haematology
|
November 10, 2009
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)
Gheath Alatrash, Maher Albitar, Susan O'Brien, et al.
British Journal of Haematology
|
February 13, 2003
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia
William G Wierda, Marcella M Johnson, Kim-Anh Do, et al.
Cancer
|
April 4, 2006
Thalidomide therapy for myelofibrosis with myeloid metaplasia
Deborah A Thomas, Francis J Giles, Maher Albitar, et al.
Cancer
|
December 12, 2003
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia
Susan M O'Brien, Hagop M Kantarjian, Deborah A Thomas, et al.
BMC Medical Genetics
|
November 17, 2010
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome
Wanlong Ma, Hagop Kantarjian, Ke Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
Michael J Keating, Susan O'Brien, Maher Albitar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2020
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model
Inhye E Ahn, Xin Tian, David Ipe, et al.
Cancers
|
April 13, 2024
Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell Transplantation
Scott D Rowley, Thomas S Gunning, Michael Pelliccia, et al.
Blood
|
May 6, 2003
Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome
Hesham M Amin, Iman Jilani, Elihu H Estey, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 214) with videos related to
Sort By:
Page
of 22
Cancer
|
August 27, 2004
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies
Maher Albitar, Kim-Anh Do, Marcella M Johnson, et al.
British Journal of Haematology
|
November 10, 2009
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)
Gheath Alatrash, Maher Albitar, Susan O'Brien, et al.
British Journal of Haematology
|
February 13, 2003
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia
William G Wierda, Marcella M Johnson, Kim-Anh Do, et al.
Cancer
|
April 4, 2006
Thalidomide therapy for myelofibrosis with myeloid metaplasia
Deborah A Thomas, Francis J Giles, Maher Albitar, et al.
Cancer
|
December 12, 2003
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia
Susan M O'Brien, Hagop M Kantarjian, Deborah A Thomas, et al.
BMC Medical Genetics
|
November 17, 2010
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome
Wanlong Ma, Hagop Kantarjian, Ke Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
Michael J Keating, Susan O'Brien, Maher Albitar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2020
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model
Inhye E Ahn, Xin Tian, David Ipe, et al.
Cancers
|
April 13, 2024
Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell Transplantation
Scott D Rowley, Thomas S Gunning, Michael Pelliccia, et al.
Blood
|
May 6, 2003
Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome
Hesham M Amin, Iman Jilani, Elihu H Estey, et al.
Page
of 22